QMS Medical Allied Services Limited (QMSMEDI) fundamentals
QMS Medical Allied Services Limited is a listed company, part of the Trading sector, listed on the NSE as QMSMEDI (ISIN INE0FMW01018). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What QMS Medical Allied Services Limited does
QMS Medical Allied Services Limited is an India-based healthcare company specializing in patient screening services and the supply of advanced diagnostic medical devices. Through its Patient Service Programs (PSP), the Company provides patients nationwide with access to critical diagnostic tests for conditions such as osteoporosis, diabetes mellitus, chronic obstructive pulmonary disease, and hypertension. The Company’s segment is Healthcare Equipments/Supplies & Services. The Company’s products include B2B Sales, E-Commerce and Point of Care. Its services include Patient Service Programs and Educamedics. The Company distributes products from various companies as well as its own brand, Q Devices. Its comprehensive solutions for patient care include tele counseling, in clinic activation, advanced respiratory screening programs, and orthopedic screening and wellness programs. Educamedics is a division of the Company offering customized solutions in the field of scientific education.
Valuation and market data
| Last close | ₹157.98 |
|---|---|
| Market capitalisation | ₹320 crore |
| Enterprise value | ₹328 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.98 |
| Price to sales (TTM) | 1.73 |
| Book value per share | ₹52.93 |
| Dividend yield | 31.65% |
| Sector | Trading |
| Industry | — |
| Listed since | Thu Jun 18 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹174 crore | ₹16 crore | ₹12 crore | 0.00 |
| Mar 2025 | ₹158 crore | ₹19 crore | ₹14 crore | 6.77 |
| Mar 2024 | ₹123 crore | ₹12 crore | ₹9 crore | 5.04 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 68.1% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 1.6% |
| Retail and others | 30.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.